Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2026-01-18 @ 5:29 PM
Study NCT ID:
NCT05574335
Status:
TERMINATED
Last Update Posted:
2025-12-19
First Post:
2022-09-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Siplizumab in T1DM
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-20
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-19
First Submit QC Date:
None
Study First Post Date:
2022-10-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-17
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED